Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss
Public ClinicalTrials.gov record NCT00163137. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Double-Blind Placebo-Controlled Trial Of The Safety, Toleration and Efficacy Of Lasofoxifene 0.25 Mg/D and Raloxifene 60Mg/D For The Prevention Of Bone Loss In Postmenopausal Women
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To compare the effects of 2 years of lasofoxifene treatment with 2 years of raloxifene 60 mg/day use and 2 years of placebo use on bone mineral density (BMD) of the lumbar spine.
Study identification
- NCT ID
- NCT00163137
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 540 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 48 Years to 75 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2003 (Type not available)
- Primary completion
- Oct 2005 (Actual)
- Completion
- Oct 2005 (Actual)
- Last update posted
- Aug 12, 2011
2003 – 2005
United States locations
- U.S. sites
- 72
- U.S. states
- 20
- U.S. cities
- 52
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Albany | California | 94706 | — |
| Pfizer Investigational Site | Berkeley | California | 94705 | — |
| Pfizer Investigational Site | La Jolla | California | 92037 | — |
| Pfizer Investigational Site | La Jolla | California | 92093-0659 | — |
| Pfizer Investigational Site | Oakland | California | 94609 | — |
| Pfizer Investigational Site | Oakland | California | 94612 | — |
| Pfizer Investigational Site | Palo Alto | California | 94304 | — |
| Pfizer Investigational Site | Poway | California | 92064 | — |
| Pfizer Investigational Site | San Diego | California | 92103 | — |
| Pfizer Investigational Site | San Diego | California | 92123 | — |
| Pfizer Investigational Site | San Diego | California | 92128 | — |
| Pfizer Investigational Site | Newark | Delaware | 19713-2094 | — |
| Pfizer Investigational Site | Brandon | Florida | 33511-5964 | — |
| Pfizer Investigational Site | Gainesville | Florida | 32605 | — |
| Pfizer Investigational Site | Gainesville | Florida | 32607 | — |
| Pfizer Investigational Site | Key Largo | Florida | 33037 | — |
| Pfizer Investigational Site | Lake Worth | Florida | 33461 | — |
| Pfizer Investigational Site | Leesburg | Florida | 34748 | — |
| Pfizer Investigational Site | Miami | Florida | 33143 | — |
| Pfizer Investigational Site | Miami | Florida | 33173 | — |
| Pfizer Investigational Site | Miami | Florida | 33176 | — |
| Pfizer Investigational Site | Tampa | Florida | 33607 | — |
| Pfizer Investigational Site | Tampa | Florida | 33613-3946 | — |
| Pfizer Investigational Site | Tampa | Florida | 33614-7118 | — |
| Pfizer Investigational Site | West Palm Beach | Florida | 33407 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30308 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60610 | — |
| Pfizer Investigational Site | Des Moines | Iowa | 50309 | — |
| Pfizer Investigational Site | Wichita | Kansas | 67207 | — |
| Pfizer Investigational Site | Portland | Maine | 04102 | — |
| Pfizer Investigational Site | Bethesda | Maryland | 20817 | — |
| Pfizer Investigational Site | Gaithersberg | Maryland | 20886 | — |
| Pfizer Investigational Site | Detroit | Michigan | 48201 | — |
| Pfizer Investigational Site | Detroit | Michigan | 48236 | — |
| Pfizer Investigational Site | Southfield | Michigan | 48034 | — |
| Pfizer Investigational Site | Arden Hills | Minnesota | 55112 | — |
| Pfizer Investigational Site | Minneapolis | Minnesota | 55415-1226 | — |
| Pfizer Investigational Site | Albuquerque | New Mexico | 87102 | — |
| Pfizer Investigational Site | Albuquerque | New Mexico | 87106 | — |
| Pfizer Investigational Site | Akron | Ohio | 44312-1647 | — |
| Pfizer Investigational Site | Akron | Ohio | 44314 | — |
| Pfizer Investigational Site | Cleveland | Ohio | 44195 | — |
| Pfizer Investigational Site | Portland | Oregon | 97213 | — |
| Pfizer Investigational Site | Portland | Oregon | 97220 | — |
| Pfizer Investigational Site | Monessen | Pennsylvania | 15062 | — |
| Pfizer Investigational Site | Mosessen | Pennsylvania | 15062 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15213 | — |
| Pfizer Investigational Site | West Reading | Pennsylvania | 19611 | — |
| Pfizer Investigational Site | Wyomissing | Pennsylvania | 19610-2132 | — |
| Pfizer Investigational Site | Wyomissing | Pennsylvania | 19610 | — |
| Pfizer Investigational Site | Chattanooga | Tennessee | 37403 | — |
| Pfizer Investigational Site | Chattanooga | Tennessee | 37412 | — |
| Pfizer Investigational Site | Cordova | Tennessee | 38018 | — |
| Pfizer Investigational Site | Germantown | Tennessee | 38138 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38119 | — |
| Pfizer Investigational Site | Nashville | Tennessee | 37203 | — |
| Pfizer Investigational Site | Dallas | Texas | 75230 | — |
| Pfizer Investigational Site | American Fork | Utah | 84003 | — |
| Pfizer Investigational Site | Pleasant Grove | Utah | 84062 | — |
| Pfizer Investigational Site | Provo | Utah | 84064 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84102 | — |
| Pfizer Investigational Site | West Jordan | Utah | 84088 | — |
| Pfizer Investigational Site | Chesapeake | Virginia | 23320 | — |
| Pfizer Investigational Site | Norfolk | Virginia | 23502 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23221 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23225 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23229 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23294 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23454 | — |
| Pfizer Investigational Site | Virginia Beach | Virginia | 23454 | — |
| Pfizer Investigational Site | Seattle | Washington | 98104 | — |
| Pfizer Investigational Site | Seattle | Washington | 98144 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00163137, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 12, 2011 · Synced Nov 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00163137 live on ClinicalTrials.gov.